Creative Biolabs provides small molecule DMPK evaluation services, quantifying metabolic stability, plasma protein binding, and drug-drug interactions. We deliver high-resolution pharmacokinetic data to evaluate clearance and bioavailability for lead optimization.
Learn More →Integrated Small Molecule DMPK & Toxicology Evaluation Services
Creative Biolabs provides a robust bridge between hit identification and studies. By evaluating molecules through an integrated lens, we deliver actionable insights that allow for the rapid prioritization of structural classes based on their real-world biological potential rather than just in vitro potency. Our approach addresses the multi-parameter nature of lead optimization, ensuring that a molecule's structure-activity relationship (SAR) is perfectly balanced with its structure-property relationship (SPR).
Background Featured Services Workflow Publication Why Choose Us FAQs Customer Review Related Services Contact Us
Strategic Foundations of Integrated DMPK and Toxicology
The transition from a validated hit to a successful candidate represents the most treacherous "valley of death" in small molecule discovery. As established in critical literature, the modern drug development paradigm demands an equilibrium between target potency, favorable pharmacokinetic disposition, and a robust safety profile. Historical data indicate that a significant majority of development failures are not caused by a lack of efficacy, but rather by unforeseen metabolic liabilities or off-target toxicities that were not identified early enough in the pipeline.
Comprehensive Evaluation Platforms
Creative Biolabs offers an expansive suite of evaluation platforms designed to provide a 360-degree view of your molecule's potential. Our offerings include:
Small Molecule DMPK Evaluation
Small Molecule Safety Pharmacology Evaluation
Creative Biolabs provides comprehensive safety pharmacology evaluation services, delivering core battery tests for cardiovascular, respiratory, and CNS systems. We offer hERG screening and telemetry models to ensure regulatory success.
Learn More →Small Molecule Toxicology Evaluation
Creative Biolabs provides comprehensive small molecule toxicology evaluation services, offering in vitro and in vivo assessments. We quantify hepatotoxicity, cardiotoxicity, and genotoxicity to identify safety liabilities and ensure regulatory success.
Learn More →Small Molecule Toxicokinetic & Exposure Integration
Creative Biolabs provides small molecule toxicokinetic and exposure integration services, merging in vivo PK/PD data with toxicological profiling. We quantify systemic exposure and dose-response relationships to define safety margins and de-risk submissions.
Learn More →Advance Your Leads with Data-Driven Precision - Inquire About Our Multi-Tiered Evaluation Platforms
Workflow
Our standardized yet highly customizable workflow is designed to provide maximum transparency and rigorous data validation at every stage of the evaluation process.
Publication
This review explores how machine learning is transforming predictive toxicology by addressing key limitations of traditional methods, including poor human translation, high costs, and ethical concerns. AI models leverage large-scale datasets, omics, chemical properties, and electronic health records to predict adverse drug reactions with greater accuracy and efficiency. The article discusses validation techniques, hybrid approaches integrating AI with conventional testing, and the potential to reduce animal use while accelerating safe drug discovery. Challenges in data quality, interpretability, and regulatory acceptance are also examined.
Fig.1 A critical review of the limitations of traditional toxicity testing. 1
Why Choose Us?
Choosing Creative Biolabs means partnering with a leader at the intersection of decades of drug discovery experience and cutting-edge biotechnology. Our core advantage lies in our unique "systems pharmacology" framework, which transcends traditional linear testing by viewing the drug-body interaction as a complex, dynamic network. This holistic methodology allows us to identify hidden systemic risks and idiosyncratic toxicities that traditional reductionist models often fail to detect until it is too late. Our platforms are designed for maximum flexibility, offering everything from rapid, high-throughput spot checks of chemical libraries to intricate, multi-species mechanistic studies using humanized organoid models.
Leverage the Creative Biolabs Advantage - Request a Custom Quote Tailored to Your Modality
FAQs
How early should I begin DMPK/toxicology testing?
Creative Biolabs recommends initiating in silico de-risking as early as the hit-to-lead stage. Early identification of metabolic or toxicity alerts allows for safer, more efficient structural optimization.
Can your platforms handle non-traditional modalities?
Absolutely. Creative Biolabs has developed specialized protocols for complex small molecules, focusing on ternary complex stability and "beyond the rule of five" solubility challenges.
How do you protect intellectual property for chemical structures?
We prioritize client confidentiality. All projects are governed by strict non-disclosure agreements (NDAs), and sensitive structure data is handled through secure, isolated servers.
Customer Review
-
Precision Safety Modeling
Using Creative Biolabs' integrated small molecule DMPK and toxicology evaluation services has significantly facilitated our safety filing for the project. Their GSH-trapping data were essential for regulatory approval. - Dr. Al** son -
Seamless Data Integration
The transition from hit to lead was remarkably smooth. Their in silico target fishing identified a hERG risk that our internal screens missed, saving us months of rework. - Prof. Ma** thew
Related Services
Pre-enzyme Drug Chemical Synthesis Service
Creative Biolabs provides ADEPT prodrug synthesis services, specializing in multi-step chemical synthesis and structural optimization. We develop enzyme-activated precursors to ensure targeted drug release and enhance therapeutic selectivity in oncology.
Learn More →Function Assays for Immune Checkpoint
Creative Biolabs provides a comprehensive immune checkpoint functional assay platform, quantifying T-cell activation, proliferation, and cytotoxicity. We offer MLR assays and cytokine release profiles to validate checkpoint inhibitor efficacy and safety.
Learn More →How to Contact Creative Biolabs
Creative Biolabs offers a comprehensive suite of integrated small molecule DMPK and toxicology evaluation services designed to bridge the gap between chemical potency and successful development. By utilizing a tiered screening approach and state-of-the-art systems pharmacology, we provide the clarity needed to advance your most promising molecules with confidence. Our commitment to accuracy, efficiency, and safety makes us the preferred partner for drug discovery teams worldwide.
Contact Creative Biolabs today to schedule a consultation with our scientific team and accelerate your lead optimization program.
Reference
- Ajisafe, O. M., et al. "The role of machine learning in predictive toxicology: A review of current trends and future perspectives." Life Sci 378 (2025): 123821. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1016/j.lfs.2025.123821
Download our brochureLoading case studies...
Online Inquiry